Information Technology [ 6/12 ] | Semiconductors & Semiconductor Equipment [ 4/73 ]
NASDAQ | Common Stock
Scinai Immunotherapeutics Ltd., a biopharmaceutical company, focuses on developing, manufacturing, and commercializing inflammation and immunology biological products for the treatment of infectious and autoimmune diseases in Israel.
It develops nanosized VHH antibodies (nanoAbs) targeting diseases with unmet medical needs; and PC111, a monoclonal antibody for treating pemphigus, steven johnson's syndrome, and toxic epidermal necrolysis.
The company also provides contract development and manufacturing organization services to biotech companies.
It has licensing and collaboration agreement with Max Planck Society and University Medical Center Gottingen for the development and commercialization of COVID-19 nanosized antibody.
The company was formerly known as BiondVax Pharmaceuticals Ltd. and changed its name to Scinai Immunotherapeutics Ltd. in September 2023.
Scinai Immunotherapeutics Ltd. was incorporated in 2003 and is headquartered in Jerusalem, Israel.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Sep 2, 25 | -2.60 Increased by +39.67% | - |
| May 7, 25 | 4.31 Increased by +1.02 K% | - |
| Feb 26, 25 | -2.64 Increased by +89.02% | - |
| Nov 22, 24 | 12.39 Increased by +1.45 K% | - |
| Jul 2, 24 | -4.31 Decreased by -288.25% | - |
| May 15, 24 | -0.47 Increased by +56.88% | -0.62 Increased by +24.19% |
| Dec 31, 23 | -24.00 Decreased by -827.69 K% | -6.20 Decreased by -287.10% |
| Oct 31, 23 | 0.80 Increased by +13.21 K% | -0.99 Increased by +180.81% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Jun 30, 25 | 386.50 K Increased by +36.09% | -2.07 M Increased by +10.98% | Decreased by -534.80% Increased by +34.59% |
| Mar 31, 25 | 386.50 K Increased by +N/A% | -1.55 M Increased by +28.25% | Decreased by -400.78% Decreased by N/A% |
| Dec 31, 24 | 206.00 K Increased by +N/A% | -2.23 M Increased by +4.29% | Decreased by -1.08 K% Decreased by N/A% |
| Sep 30, 24 | 168.00 K Increased by +N/A% | 10.46 M Increased by +236.50% | Increased by +6.22 K% Decreased by N/A% |
| Jun 30, 24 | 284.00 K Increased by +N/A% | -2.32 M Increased by +38.28% | Decreased by -817.61% Decreased by N/A% |
| Mar 31, 24 | 0.00 Decreased by N/A% | -2.16 M Increased by +38.58% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 23 | 0.00 Decreased by N/A% | -2.33 M Decreased by -340.45% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 23 | 0.00 Decreased by N/A% | 3.11 M Increased by +195.62% | Increased by +N/A% Decreased by N/A% |